Clinical Trial

Evaluation of Mosquito Repellent Products' Efficacy, Safety, and Public Health Implications

Completed
View on ClinicalTrials.gov →
Summary
Human Volunteer Participation: A total of six (6) healthy adult volunteers participated in the study, including three males and three females aged between 18 and 22 years. The volunteers participated in: * Arm-in-Cage Test Procedure * Dermatological Safety Test All participants were: * Non-tobacco users * Free from dermatosis or chronic skin disease * Free from known allergic reactions to arthropod bites or mosquito repellents * Informed regarding the objectives, procedures, risks, and benefits of the study Written informed consent was obtained from all volunteers before participation. Participants were instructed not to apply perfumes, aromatics, skincare products, or other mosquito repellents on the hands for at least 12 hours before and during the experiment to minimize experimental bias. Safety and Ethical Considerations: 1. All experiments were conducted under controlled laboratory conditions. 2. Appropriate safety precautions and monitoring procedures were maintained throughout the study. 3. Volunteers retained the right to withdraw from the study at any stage without penalty. 4. Confidentiality and anonymity of volunteer information were strictly maintained. 5. No severe physical or psychological risk was associated with participation. 6. Immediate medical support and first-aid facilities were available during experimentation.
Trial Details
NCT Number NCT07686159
Lead Sponsor Military Institute of science and Technology
Collaborators: Texas A&M University, University of Washington, Swiss Tropical and Public Health Institute (Switzerland), Chinese Academy of Sciences, Tsinghua University, University of Basel
Conditions Mosquito Repellent, Mosquito Bite
Enrollment 6 participants
Start Date 2025-09-25
Primary Completion 2025-10-25 (estimated)
Study Completion 2025-11-05 (estimated)
Updated on ClinicalTrials.gov 2026-07-07